Myasthenia gravis exacerbation associated with pembrolizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Myasthenia gravis exacerbation associated with pembrolizumab

Published:2016-03-12 Issue:3 Volume:54 Page:506-507
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Zhu Julia¹,Li Yuebing¹

Affiliation:

1. Neuromuscular Center, Desk S90 Department of Neurology; Cleveland Clinic; Cleveland Ohio USA 44195

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.25055/fullpdf

Reference7 articles.

1. PD-1 as a potential target in cancer therapy;NcDermott;Cancer Med,2013

2. Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma;Chan;J Immunother,2015

3. Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer;Loochtan;Muscle Nerve,2015

4. Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma;Shirai;Jpn J Clin Oncol,2016

5. Myasthenia gravis induced by ipilimumab in patients with metastatic melanoma;Johnson;J Clin Oncol,2014

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders;Current Neurology and Neuroscience Reports;2023-10-23

2. Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors;Frontiers in Neuroscience;2023-06-29

3. Acetylcholine receptor binding antibody–associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: A case report and literature review;Frontiers in Oncology;2022-12-08

4. Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review;Frontiers in Neurology;2022-04-07

5. Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice;Neurological Sciences;2022-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3